204 related articles for article (PubMed ID: 12037728)
21. Intermediate postchallenge hyperglycemia in overweight and obese subjects: a new marker of impaired glucose regulation?
Diamantopoulos EJ; Andreadis EA; Tsourous GI; Katsanou PM; Georgiopoulos DX; Dimitriadis GD; Raptis SA
Angiology; 2006 Dec-2007 Jan; 57(6):709-16. PubMed ID: 17235111
[TBL] [Abstract][Full Text] [Related]
22. Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.
Mori Y; Hoshino K; Yokota K; Yokose T; Tajima N
Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):334-9. PubMed ID: 15977101
[TBL] [Abstract][Full Text] [Related]
23. Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects.
Guerrero-Romero F; Rodríguez-Morán M
Diabetes Metab; 2003 Feb; 29(1):65-71. PubMed ID: 12629450
[TBL] [Abstract][Full Text] [Related]
24. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
[TBL] [Abstract][Full Text] [Related]
25. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
Kopp HP; Kopp CW; Festa A; Krzyzanowska K; Kriwanek S; Minar E; Roka R; Schernthaner G
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1042-7. PubMed ID: 12714437
[TBL] [Abstract][Full Text] [Related]
26. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).
Festa A; D'Agostino R; Howard G; Mykkänen L; Tracy RP; Haffner SM
Circulation; 2000 Jul; 102(1):42-7. PubMed ID: 10880413
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory markers in women with a recent history of gestational diabetes mellitus.
Di Benedetto A; Russo GT; Corrado F; Di Cesare E; Alessi E; Nicocia G; D'Anna R; Cucinotta D
J Endocrinol Invest; 2005 Jan; 28(1):34-8. PubMed ID: 15816369
[TBL] [Abstract][Full Text] [Related]
28. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
Festa A; Williams K; Hanley AJ; Haffner SM
Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
[TBL] [Abstract][Full Text] [Related]
29. The homeostasis model in the San Antonio Heart Study.
Haffner SM; Miettinen H; Stern MP
Diabetes Care; 1997 Jul; 20(7):1087-92. PubMed ID: 9203442
[TBL] [Abstract][Full Text] [Related]
30. Elevated A1C is associated with impaired early-phase insulin secretion rather than insulin resistance in Koreans at high risk for developing diabetes.
Kim TN; Park MS; Lee SK; Yang SJ; Lee KW; Nam M; Park YS; Woo JT; Kim YS; Baik SH
Endocrine; 2012 Dec; 42(3):584-91. PubMed ID: 22552911
[TBL] [Abstract][Full Text] [Related]
31. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention.
Osei K; Rhinesmith S; Gaillard T; Schuster D
Diabetes Care; 2004 Jun; 27(6):1439-46. PubMed ID: 15161801
[TBL] [Abstract][Full Text] [Related]
32. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.
Han TS; Sattar N; Williams K; Gonzalez-Villalpando C; Lean ME; Haffner SM
Diabetes Care; 2002 Nov; 25(11):2016-21. PubMed ID: 12401749
[TBL] [Abstract][Full Text] [Related]
33. Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.
Diabetes Prevention Program Research Group
Diabetes Care; 2005 Oct; 28(10):2472-9. PubMed ID: 16186282
[TBL] [Abstract][Full Text] [Related]
34. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
35. Novel Protein Glycan-Derived Markers of Systemic Inflammation and C-Reactive Protein in Relation to Glycemia, Insulin Resistance, and Insulin Secretion.
Lorenzo C; Festa A; Hanley AJ; Rewers MJ; Escalante A; Haffner SM
Diabetes Care; 2017 Mar; 40(3):375-382. PubMed ID: 28031420
[TBL] [Abstract][Full Text] [Related]
36. CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity.
Fernández-Real JM; Broch M; Richart C; Vendrell J; López-Bermejo A; Ricart W
J Clin Endocrinol Metab; 2003 Apr; 88(4):1780-4. PubMed ID: 12679473
[TBL] [Abstract][Full Text] [Related]
37. Determining pancreatic β-cell compensation for changing insulin sensitivity using an oral glucose tolerance test.
Solomon TP; Malin SK; Karstoft K; Knudsen SH; Haus JM; Laye MJ; Pedersen M; Pedersen BK; Kirwan JP
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E822-9. PubMed ID: 25184989
[TBL] [Abstract][Full Text] [Related]
38. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneous relationship of early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity.
Yoshinaga H; Kosaka K
Diabetes Res Clin Pract; 1999 May; 44(2):129-36. PubMed ID: 10414932
[TBL] [Abstract][Full Text] [Related]
40. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
